Literature DB >> 11427519

Heparanase as mediator of angiogenesis: mode of action.

M Elkin1, N Ilan, R Ishai-Michaeli, Y Friedmann, O Papo, I Pecker, I Vlodavsky.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11427519     DOI: 10.1096/fj.00-0895fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


× No keyword cloud information.
  103 in total

Review 1.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Multiplexed digital quantification of binge-like alcohol-mediated alterations in maternal uterine angiogenic mRNA transcriptome.

Authors:  Jayanth Ramadoss; Ronald R Magness
Journal:  Physiol Genomics       Date:  2012-04-24       Impact factor: 3.107

3.  Transcriptional regulation of the assT-dsbL-dsbI gene cluster in Salmonella enterica serovar Typhi IMSS-1 depends on LeuO, H-NS, and specific growth conditions.

Authors:  A L Gallego-Hernández; I Hernández-Lucas; M A De la Cruz; L Olvera; E Morett; L Medina-Aparicio; J A Ramírez-Trujillo; A Vázquez; M Fernández-Mora; E Calva
Journal:  J Bacteriol       Date:  2012-02-17       Impact factor: 3.490

4.  Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis.

Authors:  Marina Weissmann; Gil Arvatz; Netanel Horowitz; Sari Feld; Inna Naroditsky; Yi Zhang; Mary Ng; Edward Hammond; Eviatar Nevo; Israel Vlodavsky; Neta Ilan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-04       Impact factor: 11.205

Review 5.  Heparan sulfate proteoglycans and their binding proteins in embryo implantation and placentation.

Authors:  Catherine B Kirn-Safran; Sonia S D'Souza; Daniel D Carson
Journal:  Semin Cell Dev Biol       Date:  2007-07-31       Impact factor: 7.727

6.  Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression.

Authors:  Victoria Cohen-Kaplan; Ilana Doweck; Inna Naroditsky; Israel Vlodavsky; Neta Ilan
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 7.  Heparanase regulation of cancer, autophagy and inflammation: new mechanisms and targets for therapy.

Authors:  Ralph D Sanderson; Michael Elkin; Alan C Rapraeger; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2016-11-16       Impact factor: 5.542

8.  A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Gil Arvatz; Svetlana Gingis-Velitski; Flonia Levy-Adam; Ofer Nativ; Ronen Shemesh; Michal Ayalon-Sofer; Neta Ilan; Israel Vlodavsky
Journal:  FASEB J       Date:  2009-12-09       Impact factor: 5.191

Review 9.  Mechanisms of heparanase inhibitors in cancer therapy.

Authors:  Benjamin Heyman; Yiping Yang
Journal:  Exp Hematol       Date:  2016-08-26       Impact factor: 3.084

10.  Low and high affinity receptors mediate cellular uptake of heparanase.

Authors:  Olga Ben-Zaken; Itay Shafat; Svetlana Gingis-Velitski; Haim Bangio; Idil Kasuto Kelson; Tal Alergand; Yehudit Amor; Ruth Ben-Yakar Maya; Israel Vlodavsky; Neta Ilan
Journal:  Int J Biochem Cell Biol       Date:  2007-09-29       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.